Treatment of anxiety neurosis by alpha and beta adrenergic blocking agents.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011433:Propranolol / Q000008:administration & dosage; D014268:Trifluoperazine / Q000008:administration & dosage
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D014268:Trifluoperazine; D011433:Propranolol